A detailed history of Wilkinson Global Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wilkinson Global Asset Management LLC holds 3,380 shares of NVO stock, worth $474,653. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,380
Previous 2,980 13.42%
Holding current value
$474,653
Previous $308,000 40.58%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $40,844 - $54,367
400 Added 13.42%
3,380 $433,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $271,001 - $594,629
2,980 New
2,980 $271,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $317B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wilkinson Global Asset Management LLC Portfolio

Follow Wilkinson Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkinson Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilkinson Global Asset Management LLC with notifications on news.